Table 3.

Myocardial Infarction and Ischemic Stroke According to Transplant Status Among Patients with End-Stage Renal Disease Due to Lupus Nephritis

Cardiovascular Event	Incident Rate* (95% CI)	Unadjusted HR (95% CI)	Fully-Adjusted HR† (95% CI)
Myocardial Infarction	2.1 (1.3, 2.9)
Transplanted	1.2 (1.0, 1.6)	0.10 (0.05, 0.31)	0.13 (0.08, 0.34)
Not Transplanted	2.0 (1.2, 2.8)	1.0	1.0
Ischemic Stroke	4.2 (3.3, 5.1)
Transplanted	1.7 (0.8, 2.6)	0.29 (0.16, 0.51)	0.30 (0.16, 0.54)
Not Transplanted	6.0 (4.6, 7.4)	1.0	1.0

HR, hazard ratio

^*Per 1,000 Person-years;

^†Adjusted for sex, age, race, ethnicity, ESRD-onset year, first ESRD treatment modality, comorbidity score, Organ Procurement and Transplantation Network region, and history of prior organ transplantation

Follow-up for the Not Transplanted group begins at the time of initial waitlisting for kidney transplantation and ends at either death, censoring at the time of kidney transplantation, three years after the index date, or the end of the study period (December 31, 2017). Follow-up for the Transplanted group begins at the time of kidney transplantation and ends at either death, three years after the index date, or the end of the study period.